News List

New drug delivery method, FDA approved a new epilepsy treatment

UCB announced that the USFDA has approved Nayzilam (midazolam) nasal spray for the acute treatment of seizure clusters p

Holiday Notice of Dragon Boat Festival

To all departments and employees:According to the related national legal & the actual situation of our company, we i

Long-term anti-AIDS, Combination of two schemes submits application

On April 29, 2019,the anti-AIDS long-acting two-party “cabotegravir + Ripirilin”submitted to the FDA for listing applica

For the initial treatment of HIV patients, the FDA approved the first dual-agent combination therapy

Today, the US FDA announced that it has approved the listing of the antiviral therapy Dovato (dolutegravir and lamivudin

Novartis‘s Multiple sclerosis Innovative drug approved

Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for the treatment of recur

Highly efficient trifluoromethylation and [18F]trifluoromethylation

Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, has created a new trif

Redox neutral [4+1] cyclic reaction based on C-F fracture

Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Technology and Professor R

FDA accelerates approval of no-limit cancer targeting therapy for the treatment of NTRK fusion tumors

Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a co-developed VITRAKVI

FDA approves new mechanism for listing new anti-influenza drugs

Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil), jointly developed

FDA grants Relacorilant the qualification for orphan drugs for pancreatic cancer

Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate of 5%. In the United